Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? Are Wall Street analysts favoring West Pharmaceutical’s stock now as GLP-1 drugs gain prominence? Barchart · Aug 27
Is West Pharmaceutical Stock Outperforming the S&P 500? West Pharmaceutical continues to outpace broader market gains on strong earnings momentum and supportive analyst sentiment. Barchart · Jun 15
How Is West Pharmaceutical's Stock Performance Compared to Other Healthcare Stocks? Despite West Pharmaceutical's underperformance relative to its peers on a YTD basis, Wall Street analysts remain strongly optimistic about the stock’s prospects. Barchart · Mar 13
West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector? Although West Pharmaceutical Services stock has underperformed the broader sector, analysts remain bullish about its prospects. Barchart · Dec 17, 2025
What Are Wall Street Analysts' Target Price for West Pharmaceutical Services Stock? West Pharmaceutical Services has substantially underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects, with price targets suggesting significant upside potential. Barchart · Nov 21, 2025
West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’s third-quarter 2025 earnings surpassed analyst estimates. Benzinga · Oct 23, 2025
Is West Pharmaceutical Services Stock Underperforming the Dow? Although West Pharmaceutical Services has underperformed the Dow over the past year, it has significantly outperformed in recent months, and analysts remain strongly bullish on the stock’s prospects. Barchart · Sep 17, 2025
West Pharmaceutical Stock: Is Wall Street Bullish or Bearish? Although West Pharmaceutical has underperformed relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects. Barchart · Aug 27, 2025
West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and delivery systems company delivered a robust beat on its second-quarter 2025 earnings and revenue, while also significantly raising its full-year guidance. Benzinga · Jul 24, 2025
Is West Pharmaceutical Services Stock Underperforming the Nasdaq? While West Pharmaceutical Services has underperformed the broader Nasdaq Composite over the past year, analysts remain confident in its long-term growth prospects, citing strong fundamentals and innovation-driven momentum. Barchart · Jun 17, 2025
Dividend Aristocrats Offer Safety in Market Storms. Buy These 2 Top-Rated Stocks Now. Dividend Aristocrats bring the calm with steady paychecks, making these two 'Strong Buy'-rated stocks worth a second look here. Barchart · May 15, 2025
Is West Pharmaceutical Services Stock Underperforming the S&P 500? West Pharmaceutical Services has lagged behind the broader S&P 500 Index over the past year, but analysts remain highly optimistic about its future growth potential. Barchart · Mar 21, 2025
Do Wall Street Analysts Like West Pharmaceutical Services Stock? West Pharmaceutical Services has trailed behind the broader market over the past year, yet analysts remain highly optimistic, standing by its potential for a strong rebound. Barchart · Feb 26, 2025
What You Need to Know Ahead of West Pharmaceutical Services’ Earnings Release West Pharmaceutical Services is expected to announce its fourth-quarter results in the upcoming month and analysts expect a single-digit drop in earnings. Barchart · Jan 22, 2025
Barchart · Dec 16, 2024 How Is West Pharmaceutical Services' Stock Performance Compared to Other Medical Devices Stocks? West Pharmaceutical Services has underperformed other medical devices stocks over the past year, yet analysts remain bullish on the stock’s prospects.
Barchart · Nov 25, 2024 West Pharmaceutical Services Stock Outlook: Is Wall Street Bullish or Bearish? West Pharmaceutical Services has substantially underperformed the broader market year over the past year, yet analysts remain bullish on the stock’s prospects.
Barchart · Oct 7, 2024 What to Expect From West Pharmaceutical's Next Quarterly Earnings Report West Pharmaceutical is scheduled to report its third-quarter results later this month, and analysts expect a double-digit earnings decline.
Barchart · Sep 20, 2024 West Pharmaceutical Stock: Is WST Underperforming the Healthcare Sector? Despite West Pharmaceutical underperforming the healthcare sector, Wall Street analysts remain highly optimistic about the stock’s prospects.
Barchart · Jul 9, 2024 What to Expect From West Pharmaceutical Services' Q2 2024 Earnings Report West Pharmaceutical is expected to release its second-quarter earnings later this month, and analysts project a double-digit profit dip.